Andere Sprachen Revvity, Inc.

Aktien

850943

US7140461093

RVTY

Realtime-Estimate Cboe BZX Andere Börsenplätze 20:15:52 26.04.2024			% 5 Tage	% 1. Jan.
102.7 ^USD	+0.61%		+1.88%	-5.99%

25.04.	Revvity, Inc. beschließt vierteljährliche Dividende, zahlbar am 9. August 2024	CI
25.04.	Early Check Studie zum Neugeborenen-Screening beauftragt Revvity mit der Genomsequenzierung	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Revvity Board Declares Quarterly Dividend	25.04.
Revvity, Inc. Declares Quarterly Dividend, Payable on August 9, 2024	25.04.
Revvity’s EUROIMMUN and ALPCO-GeneProof Announce Strategic Partnership to Expand CE-IVD Molecular Assay Offerings	25.04.
Revvity to Present at BofA Securities 2024 Health Care Conference	25.04.
Early Check Newborn Screening Study Taps Revvity to Provide Genome Sequencing	25.04.
Declaration of Voting Results by Revvity, Inc	24.04.
Revvity Unveils a New Era of Automated Tuberculosis Testing	24.04.
Revvity Unveils A New Era of Automated Tuberculosis Testing	24.04.
Revvity Signals Software's New Synergy Solution Redefines Collaboration between Pharma and Contract Partners	16.04.
Revvity Signals Software’s New Synergy Solution Redefines Collaboration Between Pharma and Contract Partners	15.04.
Revvity To Hold Earnings Call on Monday, April 29, 2024	04.04.
Preliminary Injunction Granted to Enforce Revvity s Rights and Cloud Software Group s Obligations Related to Spotfire Software	03.04.
Revvity Says Court Issued Preliminary Injunction Against Cloud Software Group	03.04.
Revvity Says Court Issued Preliminary Injunction Against Cloud Software Group	02.04.
Preliminary Injunction Granted to Enforce Revvity’s Rights and Cloud Software Group’s Obligations Related to Spotfire Software	02.04.
Revvity Files Lawsuit Against Partner Cloud Software Group, Reaffirms 2024 Guidance	20.03.
Revvity Files Complaint and Seeks Injunctive Relief Against Cloud Software Group	20.03.
Revvity, Inc. Re-Affirms Earnings Guidance for the Full Year 2024	20.03.
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication	18.03.
Revvity Signals Software Introduces Signals ChemDraw Offering to Set New Standard for Cloud-Native Chemistry Communication	18.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Revvity, Inc.

Aktien

850943

US7140461093

RVTY

Andere Sprachen

Filter